HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/3/E439    most recent 00336.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (14) Citing Articles via Google Scholar Google Scholar Articles by Stipanuk, M. H. Articles by Yu, A. F. Search for Related Content PubMed PubMed Citation Articles by Stipanuk, M. H. Articles by Yu, A. F.

The ubiquitin-proteasome system is responsible for cysteine-responsive regulation of cysteine dioxygenase concentration in liver

Division of Nutritional Sciences, Cornell University, Ithaca, New York 14853

Submitted 21 July 2003 ; accepted in final form 16 November 2003

Hepatic cysteine dioxygenase (CDO) activity is a critical regulator of cellular cysteine concentration and availability of cysteine for anabolic processes and is markedly higher in animals fed diets containing excess sulfur amino acids compared with those fed levels at or below the requirement. Rat hepatocytes responded to a deficiency or excess of cysteine in the culture medium with a decrease or increase in CDO level but no change in CDO mRNA level. The cysteine analog, cysteamine, but not cysteine metabolites or thiol reagents, was also effective in increasing CDO. Inhibitors of the 26S proteasome blocked CDO degradation in cysteine-deficient cells but had little or no effect on CDO concentration in hepatocytes cultured with excess cysteine. High-molecular-mass CDO-ubiquitin conjugates were observed in cells cultured in cysteine-deficient medium, whether or not proteasome inhibitor was present, but these CDO-ubiquitin conjugates were not observed in cells cultured in cysteine-supplemented medium with or without proteasome inhibitor. Similar results were observed for degradation of recombinant CDO expressed in human heptocarcinoma cells cultured in cysteine-deficient or cysteine-supplemented medium. CDO is an example of a mammalian enzyme that is robustly regulated via its substrate, with the presence of substrate blocking the ubiquitination of CDO and, hence, the targeting of CDO for proteasomal degradation. This regulation occurs in primary hepatocytes in a manner that corresponds with changes observed in intact animals.

hepatocytes; protein degradation; sulfur amino acids

This article has been cited by other articles:

				I. Ueki and M. H. Stipanuk 3T3-L1 Adipocytes and Rat Adipose Tissue Have a High Capacity for Taurine Synthesis by the Cysteine Dioxygenase/Cysteinesulfinate Decarboxylase and Cysteamine Dioxygenase Pathways J. Nutr., February 1, 2009; 139(2): 207 - 214. [Abstract] [Full Text] [PDF]

				I. Ueki and M. H. Stipanuk Enzymes of the Taurine Biosynthetic Pathway Are Expressed in Rat Mammary Gland J. Nutr., August 1, 2007; 137(8): 1887 - 1894. [Abstract] [Full Text] [PDF]

				J. E. Dominy Jr., J. Hwang, and M. H. Stipanuk Overexpression of cysteine dioxygenase reduces intracellular cysteine and glutathione pools in HepG2/C3A cells Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E62 - E69. [Abstract] [Full Text] [PDF]

				M. H. Stipanuk, J. E. Dominy Jr., J.-I. Lee, and R. M. Coloso Mammalian Cysteine Metabolism: New Insights into Regulation of Cysteine Metabolism J. Nutr., June 1, 2006; 136(6): 1652S - 1659S. [Abstract] [Full Text] [PDF]